Medications
Medication may be used along with lifestyle changes to manage
symptoms of
irritable bowel syndrome (IBS).
The goal of medication treatment is to relieve your symptoms enough
to prevent them from interfering with your daily activities, because it may not
be possible to eliminate your symptoms. Medications may be prescribed to treat
moderate to severe pain, diarrhea, or constipation that does not respond to
home treatment. No single medication has been shown to be effective in
relieving IBS over the long term.
Antidepressant medications may improve IBS symptoms even in people
who do not have depression, especially the medication class known as tricyclic
antidepressants. Anti-anxiety medications may help if anxiety contributes to
your IBS symptoms.
Medication Choices
In most cases, the choice of medication is based on your most
troublesome symptom. For example, if diarrhea is the most bothersome symptom,
using antidiarrheals or anticholinergics may be helpful.
For diarrhea
Medications that may be used to treat severe diarrhea that does
not improve with home treatment include:
For pain with anxiety or depression
The following medications may be used if long-term (chronic)
pain also occurs with anxiety or depression:
Other
Additional medications are being studied to treat IBS. Some are
not yet available for use in Canada. Medications to relax smooth muscle to
reduce abdominal pain and bloating include darifenacin, pinaverium, and
trimebutine. Trimebutine is available in Canada; both pinaverium and
trimebutine are available in Europe.
What To Think About
Since few medications have proven consistently helpful and
because all medications have side effects, medication should be used for
specific symptoms that disrupt your normal daily activities.
If you also have another illness, such as depression, that
triggers symptoms of irritable bowel syndrome, medication treatment for that
illness may be needed.
Advisory. Health Canada and the U.S. Food
and Drug Administration (FDA) have issued advisories to patients, families, and
health professionals to closely monitor adults and children taking
antidepressants for warning signs of suicide. This is especially important at
the beginning of treatment or when doses are changed.
Health Canada and the FDA also advise that patients be observed
for increases in anxiety, panic attacks, agitation, irritability, insomnia,
impulsivity, hostility, and mania. It is most important to watch for these
behaviours in children, who may be less able to control their impulsivity as
much as adults and therefore may be at greater risk for suicidal impulses.
Health Canada and the FDA have not recommended that people stop using
antidepressants, but simply to monitor those taking the medications and, if
concerns arise, to contact a health professional.